DiviDrip · MLTX

MLTX — MoonLake Immunotherapeutics

MLTX is MoonLake Immunotherapeutics (Healthcare) — a non-dividend-paying stock. Trading at $15.01. Market cap: $1.29B. Capital Quality Rank: 57/100 — Above average.

Stock snapshot

Price$15.01
Market cap$1.29B
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)57 / 100 · Above average
ROIC (TTM)-75.3%
Shareholder buyback yield-2.47%
Altman Z-score zoneSafe

About MLTX

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Listed2022Employees130HQZug, V8SectorHealthcareWebsitemoonlaketx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside MLTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is MLTX's current stock price?

MLTX (MoonLake Immunotherapeutics) is currently trading at $15.01.

Does MLTX pay a dividend?

MLTX (MoonLake Immunotherapeutics) does not currently pay a regular dividend.

What is MLTX's Capital Quality Rank?

MLTX has a Capital Quality Rank of 57/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track MLTX in DiviDrip

Add MLTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow